Verition Fund Management »

Dyne Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $342k 36k 9.52
2025-03-31 $133k 13k 10.46
2024-12-31 $535k 23k 23.56

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Eli Lilly & Co. (LLY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Warner Bros Discovery Com Ser A (WBD)
Norfolk Southern (NSC)
Cyberark Software SHS (CYBR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)

View all positions for Verition Fund Management

Top funds holding Dyne Therapeutics

Henderson Group
Vanguard Group
BlackRock
Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
FMR
State Street Corporation
Siren
TCG Crossover Management
Adage Capital Partners GP
Citadel Advisors
Jpmorgan Chase & Co
Armistice Capital
Marshall Wace
Rtw Investments

View all funds holding Dyne Therapeutics